Atlas Legacy Advisors, LLC

Position in AMGN — Amgen Inc

CIK 2054111 LOS ANGELES, CA

Position in AMGN

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$595,324

+$88,661 QoQ

Shares Held

1,644

+14.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#2,060

of 3,140 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 86% Shared 14% None 0%

Healthcare · as of Jun 30, 2026

Atlas Legacy Advisors, LLC holds $5,121,297 across 6 Drug Manufacturers - General names. AMGN ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,579	$1,893,899
2	JNJ	Johnson & Johnson	4,361	$1,107,562
3	ABBV	AbbVie Inc.	2,607	$656,025
4	AMGN	Amgen Inc This page	1,644	$595,324
5	MRK	Merck & Co., Inc.	4,578	$588,272
6	NVS	Novartis AG	1,788	$280,215

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$595,324	1,644	+14.2%	Shares	Sole	2026-07-31
2026-03-31	$506,663	1,440	-12.9%	Shares	Other	2026-05-11
2025-12-31	$541,043	1,653	+7.1%	Shares	Other	2026-01-29
2025-09-30	$435,716	1,544	+20.7%	Shares	Other	2025-10-30
2025-06-30	$357,109	1,279	-27.8%	Shares	Sole	2025-08-06
2025-03-31	$552,066	1,772	+6.1%	Shares	Sole	2025-05-07
2024-12-31	$435,268	1,670	—	Shares	Sole	2025-01-31
No filing history on record for this holder in this stock.